
21 Partners' Almaviva Sante acquires two French clinics
Almaviva Sante, portfolio company of 21 Partners, has acquired French private healthcare clinics Axium and Clinique Toutes Aures.
Société Générale, OBC Neuflize and Caisse d'Epargne Provence Alpes Corse provided a senior debt package for the acquisition. Société Générale also provided mezzanine funding, advised by Hogan Lovells.
Follwing the acquisition, Almaviva Sante will have an 800-bed capacity, allowing it to perform up to 800,000 surgeries per year. The expected turnover of the consolidated group in 2012 is €100m.
Almaviva has acquired seven clinics since it was first bought by 21 Partners in June 2007 for less than €25m.
Company
Axium is a clinic in Aix en Provence that provides a range of surgical and other medical services. Its expertise include cardiology, ophtalmology, surgery and others. The clinic's 2011 turnover was €23m, with 22,000 patients treated.
Clinique Toutes Aures is based in Manosque and works in collaboration with Axium. In 2011, it registered 6,000 treatments with a turnover of €4m.
People
Senior associate Henry Huyghues Despointes led the deal on behalf of 21 Partners.
Advisers
Equity – HPML, Vincent Libaud, Marie-Laure Pichard (Legal); Lefaure Bouchony (Legal); Ernst & Young, François Rochmann, Chloé Launois (Financial due diligence); Audit Chorus Conseil (Assurance); ERM (Environmental due diligence); Socotec (Real estate due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater